Abstract:Objective To investigate the utilization of antibacterial drugs in patients with community-acquired pneumonia in Shanghai Ninth People′s Hospital, Shanghai JiaoTong University School of Medicine (“our hospital” for short). Methods The medical records diagnosed with community-acquired pneumonia in Respiratory Medicine Department of our hospital were extracted by HIS from Januaty to December 2016. The utilization of antibacterial drugs was evaluated by Principle for Clinical Application of Antibacterial Drugs (2015). Results The majority of patients were over 65 years and most of them complicated with basic diseases. The rate of using the antibacterial drugs was 100%, concerning 13 varieties of 6 major categories. The main drugs were quinolones (80.22%) and β-lactam/β-Lactamase inhibitors (53.84%). The most common way of drug approach was the combination of quinolones and β-lactam/β-lactamase inhibitors with intravenous drip, followed by oral administration. No ADRs happened in patients. Conclusion The rate of antibacterial drugs usage is high in community-acquired pneumonia patients of our hospital. The empirical antibiotic therapy is based on quinolones and β-lactam/β-Lactamase inhibitors, which conform the requirement of guidelines for the diagnosis and treatment of community-acquired pneumonia in China.
诸慧 原永芳 金剑. 我院社区获得性肺炎住院患者抗菌药物使用情况分析[J]. 中国医药导报, 2017, 14(29): 132-136.
ZHU Hui YUAN Yongfang JIN Jian. Analysis of the utilization of antibacterial drugs in patients with community-acquired pneumonia in our hospital. 中国医药导报, 2017, 14(29): 132-136.